Literature DB >> 19709889

E-Combretastatin and E-resveratrol structural modifications: antimicrobial and cancer cell growth inhibitory beta-E-nitrostyrenes.

Robin K Pettit1, George R Pettit, Ernest Hamel, Fiona Hogan, Bryan R Moser, Sonja Wolf, Sandy Pon, Jean-Charles Chapuis, Jean M Schmidt.   

Abstract

As part of a broad-based SAR investigation of E-resveratrol (strong sirtuin activator and antineoplastic) and the anticancer vascular-targeting combretastatin-type stilbenes, a series of twenty-three beta-E-nitrostyrenes was synthesized in order to evaluate potential antineoplastic, antitubulin, and antimicrobial activities. The beta-E-nitrostyrenes evaluated ranged from monosubstituted phenols to trimethoxy and 3-methoxy-4,5-methylenedioxy derivatives. Two of the beta-nitrostyrenes were synthesized as water-soluble sodium phosphate derivatives (4t, 4v). All except four (4r, 4s, 4t, 4u) of the series significantly inhibited a minipanel of human cancer cell lines. All but eight led to an IC(50) of <10 microM for inhibition of tubulin polymerization, and all except three (4l, 4t, 4v) displayed antimicrobial activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19709889     DOI: 10.1016/j.bmc.2009.07.076

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  8 in total

1.  Antineoplastic agents. 548. Synthesis of iodo- and diiodocombstatin phosphate prodrugs.

Authors:  George R Pettit; Heidi J Rosenberg; Rachel Dixon; John C Knight; Ernest Hamel; Jean-Charles Chapuis; Robin K Pettit; Fiona Hogan; Brandy Sumner; Kenneth B Ain; Brindi Trickey-Platt
Journal:  J Nat Prod       Date:  2012-02-10       Impact factor: 4.050

2.  Design, Synthesis and Biochemical Evaluation of Novel Ethanoanthracenes and Related Compounds to Target Burkitt's Lymphoma.

Authors:  Andrew J Byrne; Sandra A Bright; James P McKeown; John E O'Brien; Brendan Twamley; Darren Fayne; D Clive Williams; Mary J Meegan
Journal:  Pharmaceuticals (Basel)       Date:  2020-01-17

3.  Osteosarcoma Phenotype Is Inhibited by 3,4-Methylenedioxy-β-nitrostyrene.

Authors:  Patrick J Messerschmitt; Ashley N Rettew; Nicholas O Schroeder; Robert E Brookover; Avanti P Jakatdar; Patrick J Getty; Edward M Greenfield
Journal:  Sarcoma       Date:  2012-05-31

4.  The potential of selected Australian medicinal plants with anti-Proteus activity for the treatment and prevention of rheumatoid arthritis.

Authors:  I E Cock; V Winnett; J Sirdaarta; B Matthews
Journal:  Pharmacogn Mag       Date:  2015-05       Impact factor: 1.085

5.  β-Nitrostyrenes as Potential Anti-leishmanial Agents.

Authors:  Syed Shafi; Farhat Afrin; Mohammad Islamuddin; Garima Chouhan; Intzar Ali; Faatima Naaz; Kalicharan Sharma; Mohammad S Zaman
Journal:  Front Microbiol       Date:  2016-09-01       Impact factor: 5.640

6.  The Synthetic β-Nitrostyrene Derivative CYT-Rx20 Inhibits Esophageal Tumor Growth and Metastasis via PI3K/AKT and STAT3 Pathways.

Authors:  Wen-Chin Chiu; Yi-Chen Lee; Yu-Han Su; Yen-Yun Wang; Chun-Hao Tsai; Yi-An Hou; Chie-Hong Wang; Ying-Fong Huang; Chih-Jen Huang; Shah-Hwa Chou; Pei-Wen Hsieh; Shyng-Shiou F Yuan
Journal:  PLoS One       Date:  2016-11-22       Impact factor: 3.240

7.  Novel indole-bearing combretastatin analogues as tubulin polymerization inhibitors.

Authors:  Sunil Kumar; Samir Mehndiratta; Kunal Nepali; Manish K Gupta; Surrinder Koul; Parduman R Sharma; Ajit K Saxena; Kanaya L Dhar
Journal:  Org Med Chem Lett       Date:  2013-03-03

Review 8.  Tubulin-interactive stilbene derivatives as anticancer agents.

Authors:  Renata Mikstacka; Tomasz Stefański; Jakub Różański
Journal:  Cell Mol Biol Lett       Date:  2013-07-01       Impact factor: 5.787

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.